These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31927220)

  • 1. Mindfulness as a predictor of cognitive-behavioral therapy outcomes in inner-city adults with posttraumatic stress and substance dependence.
    Vujanovic AA; Smith LJ; Green C; Lane SD; Schmitz JM
    Addict Behav; 2020 May; 104():106283. PubMed ID: 31927220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A treatment development study of a cognitive and mindfulness-based therapy for adolescents with co-occurring post-traumatic stress and substance use disorder.
    Fortuna LR; Porche MV; Padilla A
    Psychol Psychother; 2018 Mar; 91(1):42-62. PubMed ID: 28815876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formal mindfulness practice predicts reductions in PTSD symptom severity following a mindfulness-based intervention for women with co-occurring PTSD and substance use disorder.
    Somohano VC; Kaplan J; Newman AG; O'Neil M; Lovejoy T
    Addict Sci Clin Pract; 2022 Sep; 17(1):51. PubMed ID: 36114577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonjudgmental acceptance: Associations with substance-related cue reactivity in adults with substance use disorders and posttraumatic stress.
    Vujanovic AA; Webber HE; Wardle MC; Green CE; Lane SD; Schmitz JM
    Addict Behav; 2022 Mar; 126():107211. PubMed ID: 34923324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder.
    Vrana C; Killeen T; Brant V; Mastrogiovanni J; Baker NL
    Contemp Clin Trials; 2017 Oct; 61():108-114. PubMed ID: 28765006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cognitive processing therapy-based treatment program for veterans diagnosed with co-occurring posttraumatic stress disorder and substance use disorder: The relationship between trauma-related cognitions and outcomes of a 6-week treatment program.
    Peck KR; Coffey SF; McGuire AP; Voluse AC; Connolly KM
    J Anxiety Disord; 2018 Oct; 59():34-41. PubMed ID: 30248534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective analysis of language use in cognitive-behavioral therapy: associations with symptom change in adults with co-occurring substance use disorders and posttraumatic stress.
    Jennings AN; Soder HE; Wardle MC; Schmitz JM; Vujanovic AA
    Cogn Behav Ther; 2021 Mar; 50(2):89-103. PubMed ID: 33021143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distress tolerance: prospective associations with cognitive-behavioral therapy outcomes in adults with posttraumatic stress and substance use disorders.
    Vujanovic AA; Webber HE; McGrew SJ; Green CE; Lane SD; Schmitz JM
    Cogn Behav Ther; 2022 Jul; 51(4):326-342. PubMed ID: 34994673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial.
    Vujanovic AA; Smith LJ; Green CE; Lane SD; Schmitz JM
    Contemp Clin Trials; 2018 Feb; 65():123-129. PubMed ID: 29287668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders.
    McGovern MP; Lambert-Harris C; Acquilano S; Xie H; Alterman AI; Weiss RD
    Addict Behav; 2009 Oct; 34(10):892-7. PubMed ID: 19395179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example.
    Hien DA; Campbell AN; Ruglass LM; Saavedra L; Mathews AG; Kiriakos G; Morgan-Lopez A
    J Subst Abuse Treat; 2015 Sep; 56():23-33. PubMed ID: 25907849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.
    Hien DA; Jiang H; Campbell AN; Hu MC; Miele GM; Cohen LR; Brigham GS; Capstick C; Kulaga A; Robinson J; Suarez-Morales L; Nunes EV
    Am J Psychiatry; 2010 Jan; 167(1):95-101. PubMed ID: 19917596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Exposure-Based Risk Reduction Through Family Therapy for Co-occurring Substance Use Problems and Posttraumatic Stress Disorder Symptoms Among Adolescents: A Randomized Clinical Trial.
    Danielson CK; Adams Z; McCart MR; Chapman JE; Sheidow AJ; Walker J; Smalling A; de Arellano MA
    JAMA Psychiatry; 2020 Jun; 77(6):574-586. PubMed ID: 32022827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance dependence posttraumatic stress disorder therapy. An integrated cognitive-behavioral approach.
    Triffleman E; Carroll K; Kellogg S
    J Subst Abuse Treat; 1999; 17(1-2):3-14. PubMed ID: 10435248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSD.
    Zalta AK; Held P; Smith DL; Klassen BJ; Lofgreen AM; Normand PS; Brennan MB; Rydberg TS; Boley RA; Pollack MH; Karnik NS
    BMC Psychiatry; 2018 Jul; 18(1):242. PubMed ID: 30053860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mindfulness-based cognitive therapy for Chinese adults with PTSD symptoms: protocol for a randomised controlled trial.
    Mak BSW; Zhang D; Powell CLYM; Leung MKW; Lo HHM; Yang X; Yip BHK; Lee EKP; Xu Z; Wong SYS
    BMC Psychiatry; 2024 May; 24(1):400. PubMed ID: 38812001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of integrated trauma treatment on outcomes in a racially/ethnically diverse sample of women in urban community-based substance abuse treatment.
    Amaro H; Dai J; Arévalo S; Acevedo A; Matsumoto A; Nieves R; Prado G
    J Urban Health; 2007 Jul; 84(4):508-22. PubMed ID: 17356904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice.
    Somohano VC; Rehder KL; Dingle T; Shank T; Bowen S
    J Dual Diagn; 2019; 15(4):233-242. PubMed ID: 31304887
    [No Abstract]   [Full Text] [Related]  

  • 19. Mindfulness-Oriented Recovery Enhancement versus CBT for co-occurring substance dependence, traumatic stress, and psychiatric disorders: Proximal outcomes from a pragmatic randomized trial.
    Garland EL; Roberts-Lewis A; Tronnier CD; Graves R; Kelley K
    Behav Res Ther; 2016 Feb; 77():7-16. PubMed ID: 26701171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalized HIV Stigma and Mindfulness: Associations With PTSD Symptom Severity in Trauma-Exposed Adults With HIV/AIDS.
    Gonzalez A; Locicero B; Mahaffey B; Fleming C; Harris J; Vujanovic AA
    Behav Modif; 2016 Jan; 40(1-2):144-63. PubMed ID: 26584609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.